Pomerantz LLP Issues Important Reminder to Ardent Health, Inc. Investors – ARDT

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Ardent Health, Inc. ("Ardent" or the "Company") (NYSE:ARDT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are […]

Pomerantz LLP Calls Attention to Class Action Filed Against Ultragenyx Pharmaceutical Inc. – RARE

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ:RARE).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

RR INVESTOR ALERT: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Richtech Robotics Inc. Investors

NEW YORK, NY / ACCESS Newswire / February 20, 2026 / The law firm of Kirby McInerney LLP reminds Richtech Robotics Inc. ("Richtech" or the "Company") (NASDAQ:RR) investors of the April 3, 2026 lead plaintiff deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Richtech securities between

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Beyond Meat, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BYND

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Beyond Meat, Inc. (NASDAQ:BYND) between February 27, 2025 and November 11, 2025, both dates inclusive (the "Class Period"), of the important March 24, 2026 lead plaintiff deadline. SO

Pomerantz LLP Advises Shareholders of Class Action Filing Involving REGENXBIO Inc. – RGNX

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against REGENXBIO Inc. ("Regenxbio" or the "Company") (NASDAQ:RGNX).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Pomerantz LLP Advises Shareholders of Class Action Against Ostin Technology Group Co., Ltd. – OST

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Ostin Technology Group Co., Ltd. ("Ostin" or the "Company") (NASDAQ:OST).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by

Pomerantz LLP Advises Shareholders of Class Action Against Masonite International Corporation – DOOR

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Masonite International Corporation ("Masonite" or the "Company").�� (NYSE:DOOR) Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Pomerantz LLP Brings Class Action Against Inovio Pharmaceuticals, Inc. – INO

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ:INO) and certain officers.�� The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 26-cv-00803,

Pomerantz LLP Informs Shareholders of Class Action Filing Against BellRing Brands, Inc. – BRBR

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against BellRing Brands, Inc. ("BellRing" or the "Company") (NYSE:BRBR).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Pomerantz LLP Reminds Shareholders with Losses on their Investment in agilon health, inc. – AGL

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. ("Agilon" or the "Company") (NYSE:AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Scroll to Top